Details

Autor(en) / Beteiligte

• Li, Qian
• Sun, Lihong
• Zhang, Lei
• Xu, Zhigang
• Kang, Yuejun
• Xue, Peng

Titel

Polydopamine‐collagen complex to enhance the biocompatibility of polydimethylsiloxane substrates for sustaining long‐term culture of L929 fibroblasts and tendon stem cells

Ist Teil von

• Journal of biomedical materials research. Part A, 2018-02, Vol.106 (2), p.408-418

Ort / Verlag

United States: Wiley Subscription Services, Inc

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Polydimethylsiloxane (PDMS) is a commercialized polymer extensively used in the fabrication of versatile microfluidic microdevices for studies in cell biology and tissue engineering. However, the inherent surface hydrophobicity of PDMS is not optimal for cell culture and thus restrains its applications for investigation of long‐term behaviors of fibroblasts and stem cells. To improve the surface biocompatibility of PDMS, a facile technique was developed by modifying the PDMS surface with polydopamine‐collagen (COL/PDA) complex. The successful synthesis of COL/PDA was verified through proton nuclear magnetic resonance spectroscopy. Compared to surface coating solely with COL or PDA, the surface wettability was significantly improved on COL/PDA‐modified PDMS substrates based on water contact angle characterizations. The modified PDMS surface remarkably enhanced the initial adhesion and long‐term proliferation of L929 fibroblasts and tendon stem cells (TSCs). Additionally, the effects of COL/PDA coating on cell viability and apoptosis were further investigated under prolonged incubation. We found that the COL/PDA coating on PDMS resulted in a substantial increase of cell viability compared to native PDMS, and the cell apoptosis was considerably impeded on the modified PDMS. This study demonstrated that COL/PDA coating can effectively enhance the surface biocompatibility of PDMS as verified by the enhanced adhesion and long‐term proliferation of L929 fibroblasts and TSCs. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 408–418, 2018.